Florence a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
M. Spina Z Nagy; J. M Ribera; M Federico; I Aurer; K Jordan; G Borsaru; A. S Pristupa; A Bosi; S Grosicki; N. L Glushko; D Ristic; J Jakucs; P Montesinos; J Mayer; Eduardo Magalhães Rego; S Baldini; S Scartoni; A Capriati; C. A Maggi; C Simonelli; FLORENCE Study Group
Annals of Oncology Oxford v. 26, n. 10, p. 2155-2161, 2015
Oxford 2015
Localização:
FMRP - Fac. Medicina de Ribeirão Preto
(pcd 2761310 Estantes Deslizantes )(Acessar)